Cart
sales@molnova.com
BW-A78U
CAS No. 101155-02-6
BW-A78U ( —— )
Catalog No. M19920 CAS No. 101155-02-6
BW-A 78U is a PDE4 inhibitor (IC50: 3 μM). It is not inhibition on the lipopolysaccharide (LPS)-induced TNF-α release.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 80 | In Stock |
|
| 5MG | 156 | In Stock |
|
| 10MG | 232 | In Stock |
|
| 25MG | 393 | In Stock |
|
| 50MG | 566 | In Stock |
|
| 100MG | 799 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBW-A78U
-
NoteResearch use only not for human use.
-
Brief DescriptionBW-A 78U is a PDE4 inhibitor (IC50: 3 μM). It is not inhibition on the lipopolysaccharide (LPS)-induced TNF-α release.
-
DescriptionBW-A 78U is a PDE4 inhibitor (IC50: 3 μM). It is not inhibition on the lipopolysaccharide (LPS)-induced TNF-α release.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number101155-02-6
-
Formula Weight257.27
-
Molecular FormulaC13H12FN5
-
Purity>98% (HPLC)
-
SolubilityDMSO: 100 mg/mL
-
SMILESCNc1ncnc2n(Cc3ccccc3F)cnc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Boichot E et al. Anti-inflammatory activities of a new series of selective phosphodiesterase 4 inhibitors derivedfrom 9-benzyladenine. J Pharmacol Exp Ther. 2000 Feb;292(2):647-53.
molnova catalog
related products
-
Sildenafil citrate
Sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5).
-
PF-2545920
A potent and selective PDE10A inhibitor with IC50 of 0.37 nM.
-
BAY 2666605
BAY 2666605 is an orally active inhibitor of PDE3A and PDE3B with IC50s of 87 nM and 50 nM, respectively. BAY 2666605 has anticancer effects.
